Home > Drug Search >
  • company_query: Arsanis Biosciences
  •   > 
Drug Filter
Category:
chemistry (13) biology (26)
Status:
Approved (3) Phase Ⅲ (5) Phase Ⅱ (16) Phase Ⅰ (15)
Clinical Stage:
Pending (2) Active (29) Discontinued (5)
Bio-Type:
Vaccine (5) Microbial extract (2) Recombinant cytokines (2) Whole antibody (5) Fusion protein (1)
Indication:
Acute myeloid Leukemia (AML) (1) Alzheimer's disease (AD) (1) Anemia (2) Anxiety (1) Asthma (2) Attention deficit hyperactivity disorder (ADHD) (1) Basal cell carcinoma (BCC) (1) Chronic obstructive pulmonary disease (COPD) (1) Community-acquired pneumonia (CAP) (1) Complicated intra-abdominal infection (1) Complicated urinary tract infection (1) Cystic fibrosis (CF) (1) Diabetic nephropathy (1) Endometrial cancer (1) Transplant rejection (1) Penile cancer (1) Urogenital cancer (1) Hepatocellular carcinoma (HCC) (1) Hypertension (1) Glabellar line (1) Torticollis (1) Rabies (3) Major depressive disorder (MDD) (1) Haematological disorders (1) Migraine (1) Multiple sclerosis (MS) (1) Myelodysplastic syndrome (MDS) (1) Non-Hodgkin B-cell lymphomas (1) Osteoarthritis (OA) (1) Plantar fasciitis (1) Ovarian cancer (1) Pancreatic cancer (1) Prostate cancer (2) Rheumatoid arthritis (RA) (3) Systemic lupus erythematosus (1) Tourette's syndrome (1) Venous thromboembolism (VTE) (1) Colorectal cancer (1) Pain (2) Cervical carcinoma (1) Diabetes (1) Neutropenia (1) Autoimmune diseases (1) Pressure sore (1) Staphylococcal infection (1) Allergic asthma (1) Complicated skin and soft tissue infections (1) Bullous pemphigoid (1) Organ fibrosis (1) Skin disorders (1) Human papillomavirus infections (HPV) (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top